Cargando…
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of e...
Autores principales: | Vasic, Dusica, Walcher, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321614/ https://www.ncbi.nlm.nih.gov/pubmed/22547909 http://dx.doi.org/10.1155/2012/858692 |
Ejemplares similares
-
Proinflammatory Effects of C-Peptide in Different Tissues
por: Vasic, Dusica, et al.
Publicado: (2012) -
C-Peptide and Atherogenesis: C-Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus?
por: Marx, Nikolaus, et al.
Publicado: (2008) -
C-peptide promotes lesion development in a mouse model of arteriosclerosis
por: Vasic, Dusica, et al.
Publicado: (2012) -
Ivabradine Reduces Chemokine-Induced CD4-Positive Lymphocyte Migration
por: Walcher, Thomas, et al.
Publicado: (2010) -
Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis
por: Benitez Amaro, Aleyda, et al.
Publicado: (2021)